{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T02:34:28Z","timestamp":1792722868631,"version":"4.5.0"},"reference-count":189,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001409","name":"Department of Science and Technology, Ministry of Science and Technology, India","doi-asserted-by":"publisher","award":["DST\/INSPIRE\/04\/2016\/002107"],"award-info":[{"award-number":["DST\/INSPIRE\/04\/2016\/002107"]}],"id":[{"id":"10.13039\/501100001409","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001409","name":"Department of Science and Technology, Ministry of Science and Technology, India","doi-asserted-by":"publisher","award":["DST\/INSPIRE\/04\/2019\/002454"],"award-info":[{"award-number":["DST\/INSPIRE\/04\/2019\/002454"]}],"id":[{"id":"10.13039\/501100001409","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Biological Macromolecules"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1016\/j.ijbiomac.2023.124231","type":"journal-article","created":{"date-parts":[[2023,3,28]],"date-time":"2023-03-28T12:55:36Z","timestamp":1680008136000},"page":"124231","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":76,"special_numbering":"C","title":["A\u03b2-oligomers: A potential therapeutic target for Alzheimer's disease"],"prefix":"10.1016","volume":"239","author":[{"given":"Sudeshna","family":"Ghosh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafat","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandeep","family":"Verma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijbiomac.2023.124231_bb0005","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1038\/s41593-018-0235-9","article-title":"Protein misfolding, aggregation, and conformational strains in neurodegenerative diseases","volume":"21","author":"Soto","year":"2018","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.ijbiomac.2023.124231_bb0010","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1038\/s41374-019-0231-z","article-title":"The amyloid cascade and Alzheimer's disease therapeutics: theory versus observation","volume":"99","author":"Castellani","year":"2019","journal-title":"Lab. Investig."},{"key":"10.1016\/j.ijbiomac.2023.124231_bb0015","doi-asserted-by":"crossref","first-page":"S567","DOI":"10.3233\/JAD-179941","article-title":"The amyloid-\u03b2 oligomer hypothesis: beginning of the third decade","volume":"64","author":"Cline","year":"2018","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.ijbiomac.2023.124231_bb0020","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1039\/C6CS00731G","article-title":"Towards an understanding of amyloid-\u03b2 oligomers: characterization, toxicity mechanisms, and inhibitors","volume":"46","author":"Lee","year":"2017","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.ijbiomac.2023.124231_bb0025","doi-asserted-by":"crossref","first-page":"5147","DOI":"10.1021\/cr3000994","article-title":"The amyloid Beta peptide: a Chemist\u2019s perspective. Role in Alzheimer\u2019s and fibrillization","volume":"112","author":"Hamley","year":"2012","journal-title":"Chem. Rev."},{"key":"10.1016\/j.ijbiomac.2023.124231_bb0030","doi-asserted-by":"crossref","first-page":"11234","DOI":"10.1038\/s41598-020-68148-2","article-title":"Longitudinal profiling of oligomeric A\u03b2 in human nasal discharge reflecting cognitive decline in probable Alzheimer\u2019s disease","volume":"10","author":"Yoo","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ijbiomac.2023.124231_bb0035","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1021\/acs.biomac.9b01475","article-title":"Transthyretin inhibits primary and secondary nucleations of amyloid-\u03b2 peptide aggregation and reduces the toxicity of its oligomers","volume":"21","author":"Ghadami","year":"2020","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.ijbiomac.2023.124231_bb0040","doi-asserted-by":"crossref","first-page":"8895","DOI":"10.1073\/pnas.1820585116","article-title":"\u03b1-sheet secondary structure in amyloid \u03b2-peptide drives aggregation and toxicity in Alzheimer's disease","volume":"116","author":"Shea","year":"2019","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.ijbiomac.2023.124231_bb0045","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abf9180","article-title":"Targeting Alzheimer\u2019s disease with multimodal polypeptide-based nanoconjugates","volume":"7","author":"Duro-Castano","year":"2021","journal-title":"Sci. Adv."},{"key":"10.1016\/j.ijbiomac.2023.124231_bb0050","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1146\/annurev.biochem.75.101304.123901","article-title":"Protein misfolding, functional amyloid, and human disease","volume":"75","author":"Chiti","year":"2006","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.ijbiomac.2023.124231_bb0055","doi-asserted-by":"crossref","first-page":"595","DOI":"10.15252\/emmm.201606210","article-title":"The amyloid hypothesis of Alzheimer\u2019s disease at 25 years","volume":"8","author":"Selkoe","year":"2016","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.ijbiomac.2023.124231_bb0060","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/S0014-5793(00)02076-7","article-title":"Regulation of APP cleavage by \u03b1-, \u03b2- and \u03b3-secretases","volume":"483","author":"Nunan","year":"2000","journal-title":"FEBS Lett."},{"key":"10.1016\/j.ijbiomac.2023.124231_bb0065","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1038\/nm1295-1291","article-title":"The swedish mutation causes early-onset Alzheimer\u2019s disease by \u03b2-secretase cleavage within the secretory pathway","volume":"1","author":"Haass","year":"1995","journal-title":"Nat. Med."},{"key":"10.1016\/j.ijbiomac.2023.124231_bb0070","doi-asserted-by":"crossref","first-page":"150","DOI":"10.15698\/cst2018.07.143","article-title":"Alzheimer\u2019s disease: amyloid-based pathogenesis and potential therapies","volume":"2","author":"Zhou","year":"2018","journal-title":"Cell Stress"},{"key":"10.1016\/j.ijbiomac.2023.124231_bb0075","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/S0022-2836(03)00927-6","article-title":"Mixtures of wild-type and a pathogenic (E22G) form of A\u03b240 in vitro accumulate protofibrils, including amyloid pores","volume":"332","author":"Lashuel","year":"2003","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.ijbiomac.2023.124231_bb0080","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1126\/science.1079469","article-title":"Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis","volume":"300","author":"Kayed","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.ijbiomac.2023.124231_bb0085","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1038\/nature04533","article-title":"A specific amyloid-beta protein assembly in the brain impairs memory","volume":"440","author":"Lesn\u00e9","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.ijbiomac.2023.124231_bb0090","doi-asserted-by":"crossref","first-page":"9758","DOI":"10.1073\/pnas.1218402110","article-title":"Proliferation of amyloid-\u03b242 aggregates occurs through a secondary nucleation mechanism","volume":"110","author":"Cohen","year":"2013","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.ijbiomac.2023.124231_bb0095","doi-asserted-by":"crossref","first-page":"9384","DOI":"10.1073\/pnas.1401564111","article-title":"Differences in nucleation behavior underlie the contrasting aggregation kinetics of the A\u03b240 and A\u03b242 peptides","volume":"111","author":"Meisl","year":"2014","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.ijbiomac.2023.124231_bb0100","doi-asserted-by":"crossref","first-page":"9902","DOI":"10.1073\/pnas.1422401112","article-title":"Rational design of antibodies targeting specific epitopes within intrinsically disordered proteins","volume":"112","author":"Sormanni","year":"2015","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.ijbiomac.2023.124231_bb0105","doi-asserted-by":"crossref","first-page":"13509","DOI":"10.1073\/pnas.1919464117","article-title":"Rational design of a conformation-specific antibody for the quantification of A\u03b2 oligomers","volume":"117","author":"Aprile","year":"2020","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.ijbiomac.2023.124231_bb0110","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/S0896-6273(03)00434-3","article-title":"Triple-transgenic model of Alzheimer's disease with plaques and tangles: intracellular A\u03b2 and synaptic dysfunction","volume":"39","author":"Oddo","year":"2003","journal-title":"Neuron"},{"key":"10.1016\/j.ijbiomac.2023.124231_bb0115","doi-asserted-by":"crossref","first-page":"191","DOI":"10.3389\/fncel.2015.00191","article-title":"Soluble amyloid-\u03b2 oligomers as synaptotoxins leading to cognitive impairment in Alzheimer's disease","volume":"9","author":"Ferreira","year":"2015","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.ijbiomac.2023.124231_bb0120","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/alzrt203","article-title":"On the subject of rigor in the study of amyloid \u03b2-protein assembly","volume":"5","author":"Teplow","year":"2013","journal-title":"Alzheimers Res. Ther."},{"key":"10.1016\/j.ijbiomac.2023.124231_bb0125","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1021\/cn300122k","article-title":"Synapse-binding subpopulations of A\u03b2 oligomers sensitive to peptide assembly blockers and scFv antibodies","volume":"3","author":"Velasco","year":"2012","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.ijbiomac.2023.124231_bb0130","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1016\/j.celrep.2015.05.021","article-title":"Quaternary structure defines a large class of amyloid-\u03b2 oligomers neutralized by sequestration","volume":"11","author":"Liu","year":"2015","journal-title":"Cell Rep."},{"key":"10.1016\/j.ijbiomac.2023.124231_bb0135","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1126\/science.1566067","article-title":"Alzheimer\u2019s disease: the amyloid cascade hypothesis","volume":"256","author":"Hardy","year":"1992","journal-title":"Science"},{"key":"10.1016\/j.ijbiomac.2023.124231_bb0140","doi-asserted-by":"crossref","first-page":"4820","DOI":"10.1021\/cr900377t","article-title":"Polymorphism in alzheimer A\u03b2 amyloid organization reflects conformational selection in a rugged energy landscape","volume":"110","author":"Miller","year":"2010","journal-title":"Chem. Rev."},{"key":"10.1016\/j.ijbiomac.2023.124231_bb0145","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1038\/nsmb.1437","article-title":"EGCG redirects amyloidogenic polypeptides into unstructured, off-pathway oligomers","volume":"15","author":"Ehrnhoefer","year":"2008","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.ijbiomac.2023.124231_bb0150","doi-asserted-by":"crossref","first-page":"5835","DOI":"10.1073\/pnas.1524807113","article-title":"High-speed atomic force microscopy reveals structural dynamics of amyloid \u03b21-42 aggregates","volume":"113","author":"Watanabe-Nakayama","year":"2016","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.ijbiomac.2023.124231_bb0155","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1021\/jacs.7b10343","article-title":"Pathways of amyloid-\u03b2 aggregation depend on oligomer shape","volume":"140","author":"Barz","year":"2018","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.ijbiomac.2023.124231_bb0160","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1038\/nchem.247","article-title":"Amyloid-\u03b2 protein oligomerization and the importance of tetramers and dodecamers in the aetiology of Alzheimer\u2019s disease","volume":"1","author":"Bernstein","year":"2009","journal-title":"Nat. Chem."},{"key":"10.1016\/j.ijbiomac.2023.124231_bb0165","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1021\/jacs.5b11913","article-title":"Amyloid \u03b2-protein assembly and Alzheimer's disease: dodecamers of A\u03b242, but not of A\u03b240, seed fibril formation","volume":"138","author":"Economou","year":"2016","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.ijbiomac.2023.124231_bb0170","doi-asserted-by":"crossref","first-page":"eaaz6014","DOI":"10.1126\/sciadv.aaz6014","article-title":"Complete aggregation pathway of amyloid \u03b2 (1\u201340) and (1\u201342) resolved on an atomically clean interface","volume":"6","author":"Nirmalraj","year":"2020","journal-title":"Sci. Adv."},{"key":"10.1016\/j.ijbiomac.2023.124231_bb0175","doi-asserted-by":"crossref","DOI":"10.1002\/mabi.202200489","article-title":"How single site mutations can help understanding structure formation of amyloid \u03b2(1\u201340)","author":"Schwarze","year":"2023","journal-title":"Macromol. Biosci."},{"key":"10.1016\/j.ijbiomac.2023.124231_bb0180","doi-asserted-by":"crossref","first-page":"2813","DOI":"10.1021\/acschemneuro.2c00180","article-title":"Nanoscale characterization of parallel and antiparallel \u03b2-sheet amyloid Beta 1\u201342 aggregates","volume":"13","author":"Zhaliazka","year":"2022","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.ijbiomac.2023.124231_bb0185","doi-asserted-by":"crossref","first-page":"13762","DOI":"10.1021\/jacs.9b06970","article-title":"Observation of \u03b2-amyloid peptide oligomerization by pressure-jump NMR spectroscopy","volume":"141","author":"Barnes","year":"2019","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.ijbiomac.2023.124231_bb0190","doi-asserted-by":"crossref","first-page":"4126","DOI":"10.3390\/ijms20174126","article-title":"Aggregation states of A\u03b21\u201340, A\u03b21\u201342 and A\u03b2p3\u201342 amyloid Beta peptides: a SANS study","volume":"20","author":"Festa","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ijbiomac.2023.124231_bb0195","doi-asserted-by":"crossref","first-page":"7916","DOI":"10.1021\/acs.jpcb.2c04743","article-title":"Characterization of the conformations of amyloid Beta 42 in solution that may mediate its initial hydrophobic aggregation","volume":"126","author":"Sonar","year":"2022","journal-title":"J. Phys. Chem. B"},{"key":"10.1016\/j.ijbiomac.2023.124231_bb0200","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1021\/acschemneuro.1c00784","article-title":"Taylor dispersion analysis and atomic force microscopy provide a quantitative insight into the aggregation kinetics of A\u03b2 (1\u201340)\/A\u03b2 (1\u201342) amyloid peptide mixtures","volume":"13","author":"Deleanu","year":"2022","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.ijbiomac.2023.124231_bb0205","doi-asserted-by":"crossref","first-page":"8526","DOI":"10.1039\/D2SC01555B","article-title":"Site specific NMR characterization of abeta-40 oligomers cross seeded by abeta-42 oligomers","volume":"13","author":"Chang","year":"2022","journal-title":"Chem. Sci."},{"key":"10.1016\/j.ijbiomac.2023.124231_bb0210","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.1021\/acs.jpcb.1c09995","article-title":"Cross-seeding controls A\u03b2 fibril populations and resulting functions","volume":"126","author":"Lucas","year":"2022","journal-title":"J. Phys. Chem. B"},{"key":"10.1016\/j.ijbiomac.2023.124231_bb0215","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.neuro.2022.07.006","article-title":"Effects of pramipexole on beta-amyloid1\u201342 memory deficits and evaluation of oxidative stress and mitochondrial function markers in the hippocampus of wistar rat","volume":"92","author":"Salman","year":"2022","journal-title":"Neurotoxicology."},{"key":"10.1016\/j.ijbiomac.2023.124231_bb0220","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2204581119","article-title":"Functionally linked potassium channel activity in cerebral endothelial and smooth muscle cells is compromised in Alzheimer\u2019s disease","volume":"119","author":"Taylor","year":"2022","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.ijbiomac.2023.124231_bb0225","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.bbrc.2014.04.019","article-title":"Taurine attenuates amyloid \u03b2 1\u201342-induced mitochondrial dysfunction by activating of SIRT1 in SK-N-SH cells","volume":"447","author":"Sun","year":"2014","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ijbiomac.2023.124231_bb0230","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/j.biocel.2010.01.004","article-title":"Mitochondrial medicine for neurodegenerative diseases","volume":"42","author":"Du","year":"2010","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.ijbiomac.2023.124231_bb0235","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1038\/s41594-020-0471-z","article-title":"Direct measurement of lipid membrane disruption connects kinetics and toxicity of A\u03b242 aggregation","volume":"27","author":"Flagmeier","year":"2020","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.ijbiomac.2023.124231_bb0240","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1038\/s41557-020-0452-1","article-title":"Dynamics of oligomer populations formed during the aggregation of Alzheimer's A\u03b242 peptide","volume":"12","author":"Michaels","year":"2020","journal-title":"Nat. Chem."},{"key":"10.1016\/j.ijbiomac.2023.124231_bb0245","doi-asserted-by":"crossref","first-page":"8667","DOI":"10.1039\/C8CC02204F","article-title":"Secondary nucleation in amyloid formation","volume":"54","author":"T\u00f6rnquist","year":"2018","journal-title":"Chem. Commun."},{"key":"10.1016\/j.ijbiomac.2023.124231_bb0250","doi-asserted-by":"crossref","first-page":"8005","DOI":"10.1073\/pnas.1700239114","article-title":"Monomeric and fibrillar \u03b1-synuclein exert opposite effects on the catalytic cycle that promotes the proliferation of A\u03b242 aggregates","volume":"114","author":"Chia","year":"2017","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.ijbiomac.2023.124231_bb0255","series-title":"Methods Enzymol","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/S0076-6879(99)09019-9","article-title":"Analysis of protein aggregation kinetics","author":"Ferrone","year":"1999"},{"key":"10.1016\/j.ijbiomac.2023.124231_bb0260","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.jmb.2012.02.031","article-title":"From macroscopic measurements to microscopic mechanisms of protein aggregation","volume":"421","author":"Cohen","year":"2012","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.ijbiomac.2023.124231_bb0265","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/0022-2836(85)90175-5","article-title":"Kinetics of sickle hemoglobin polymerization. II. A double nucleation mechanism","volume":"183","author":"Ferrone","year":"1985","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.ijbiomac.2023.124231_bb0270","doi-asserted-by":"crossref","first-page":"65105","DOI":"10.1063\/1.3608916","article-title":"Nucleated polymerization with secondary pathways. I. Time evolution of the principal moments","volume":"135","author":"Cohen","year":"2011","journal-title":"J. Chem. Phys."},{"key":"10.1016\/j.ijbiomac.2023.124231_bb0275","doi-asserted-by":"crossref","first-page":"7606","DOI":"10.1039\/C4CP05563B","article-title":"On the lag phase in amyloid fibril formation","volume":"17","author":"Arosio","year":"2015","journal-title":"Phys. Chem. Chem. Phys."},{"key":"10.1016\/j.ijbiomac.2023.124231_bb0280","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1038\/nsmb.2971","article-title":"A molecular chaperone breaks the catalytic cycle that generates toxic A\u03b2 oligomers","volume":"22","author":"Cohen","year":"2015","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.ijbiomac.2023.124231_bb0285","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1126\/science.1178250","article-title":"An analytical solution to the kinetics of breakable filament assembly","volume":"326","author":"Knowles","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.ijbiomac.2023.124231_bb0290","doi-asserted-by":"crossref","first-page":"4996","DOI":"10.1039\/C6SC04797A","article-title":"Pyroglutamate-modified A\u03b2(3\u201342) affects aggregation kinetics of A\u03b2(1\u201342) by accelerating primary and secondary pathways","volume":"8","author":"Dammers","year":"2017","journal-title":"Chem. Sci."},{"key":"10.1016\/j.ijbiomac.2023.124231_bb0295","doi-asserted-by":"crossref","first-page":"14673","DOI":"10.1021\/jacs.5b07849","article-title":"N-terminal extensions retard A\u03b242 fibril formation but allow cross-seeding and coaggregation with A\u03b242","volume":"137","author":"Szczepankiewicz","year":"2015","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.ijbiomac.2023.124231_bb0300","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1021\/cb400616y","article-title":"Single point mutations induce a switch in the molecular mechanism of the aggregation of the Alzheimer\u2019s disease associated A\u03b242 peptide","volume":"9","author":"Bolognesi","year":"2014","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.ijbiomac.2023.124231_bb0305","doi-asserted-by":"crossref","first-page":"E5849","DOI":"10.1073\/pnas.1803539115","article-title":"On the role of sidechain size and charge in the aggregation of A\u03b242 with familial mutations","volume":"115","author":"Yang","year":"2018","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.ijbiomac.2023.124231_bb0310","doi-asserted-by":"crossref","first-page":"eaau3112","DOI":"10.1126\/sciadv.aau3112","article-title":"Secondary nucleation and elongation occur at different sites on Alzheimer\u2019s amyloid-\u03b2 aggregates","volume":"5","author":"Scheidt","year":"2019","journal-title":"Sci. Adv."},{"key":"10.1016\/j.ijbiomac.2023.124231_bb0315","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.1700488","article-title":"Selective targeting of primary and secondary nucleation pathways in A\u03b242 aggregation using a rational antibody scanning method","volume":"3","author":"Aprile","year":"2017","journal-title":"Sci. Adv."},{"key":"10.1016\/j.ijbiomac.2023.124231_bb0320","doi-asserted-by":"crossref","first-page":"6444","DOI":"10.1073\/pnas.1700407114","article-title":"Phage display and kinetic selection of antibodies that specifically inhibit amyloid self-replication","volume":"114","author":"Munke","year":"2017","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.ijbiomac.2023.124231_bb0325","doi-asserted-by":"crossref","first-page":"11265","DOI":"10.1073\/pnas.1918481117","article-title":"Ultrastructural evidence for self-replication of alzheimer-associated A\u03b242 amyloid along the sides of fibrils","volume":"117","author":"T\u00f6rnquist","year":"2020","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.ijbiomac.2023.124231_bb0330","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/978-1-4939-7816-8_1","article-title":"Preparation of pure populations of amyloid \u03b2-protein oligomers of defined size","volume":"1779","author":"Hayden","year":"2018","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.ijbiomac.2023.124231_bb0335","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.bbapap.2015.12.001","article-title":"Stabilization of native amyloid \u03b2-protein oligomers by copper and hydrogen peroxide induced cross-linking of unmodified proteins (CHICUP)","volume":"1864","author":"Williams","year":"2016","journal-title":"Biochim. Biophys. Acta, Proteins Proteomics"},{"key":"10.1016\/j.ijbiomac.2023.124231_bb0340","doi-asserted-by":"crossref","first-page":"23580","DOI":"10.1074\/jbc.M109.038133","article-title":"Amino acid position-specific contributions to amyloid beta-protein oligomerization","volume":"284","author":"Maji","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ijbiomac.2023.124231_bb0345","doi-asserted-by":"crossref","first-page":"20597","DOI":"10.1039\/C8CP02685H","article-title":"Dynamic micellar oligomers of amyloid beta peptides play a crucial role in their aggregation mechanisms","volume":"20","author":"Morel","year":"2018","journal-title":"Phys. Chem. Chem. Phys."},{"key":"10.1016\/j.ijbiomac.2023.124231_bb0350","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1111\/j.1471-4159.2005.03407.x","article-title":"Globular amyloid beta-peptide oligomer - a homogenous and stable neuropathological protein in Alzheimer\u2019s disease","volume":"95","author":"Barghorn","year":"2005","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ijbiomac.2023.124231_bb0355","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/978-1-4939-7811-3_21","article-title":"Preparation of stable amyloid-\u03b2 oligomers without perturbative methods","volume":"1777","author":"Kotler","year":"2018","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.ijbiomac.2023.124231_bb0360","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.neuron.2014.02.027","article-title":"Soluble A\u03b2 oligomers are rapidly sequestered from brain ISF in vivo and bind GM1 ganglioside on cellular membranes","volume":"82","author":"Hong","year":"2014","journal-title":"Neuron"},{"key":"10.1016\/j.ijbiomac.2023.124231_bb0365","doi-asserted-by":"crossref","first-page":"6692","DOI":"10.1039\/C3CS60431D","article-title":"Differences between amyloid-\u03b2 aggregation in solution and on the membrane: insights into elucidation of the mechanistic details of Alzheimer\u2019s disease","volume":"43","author":"Kotler","year":"2014","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.ijbiomac.2023.124231_bb0370","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1016\/j.bbalip.2010.01.008","article-title":"Abeta polymerization through interaction with membrane gangliosides","volume":"1801","author":"Matsuzaki","year":"2010","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ijbiomac.2023.124231_bb0375","doi-asserted-by":"crossref","first-page":"3014","DOI":"10.1038\/s41467-020-16566-1","article-title":"A\u03b2(1\u201342) tetramer and octamer structures reveal edge conductivity pores as a mechanism for membrane damage","volume":"11","author":"Ciudad","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ijbiomac.2023.124231_bb0380","doi-asserted-by":"crossref","first-page":"8329","DOI":"10.1021\/acs.jpclett.0c01967","article-title":"Time-dependent lipid dynamics, organization and peptide-lipid interaction in phospholipid bilayers with incorporated \u03b2-amyloid oligomers","volume":"11","author":"Qiang","year":"2020","journal-title":"J. Phys. Chem. Lett."},{"key":"10.1016\/j.ijbiomac.2023.124231_bb0385","doi-asserted-by":"crossref","first-page":"20857","DOI":"10.1039\/C9NR06361G","article-title":"Membrane domain modulation of A\u03b2(1\u201342) oligomer interactions with supported lipid bilayers: an atomic force microscopy investigation","volume":"11","author":"Azouz","year":"2019","journal-title":"Nanoscale"},{"key":"10.1016\/j.ijbiomac.2023.124231_bb0390","doi-asserted-by":"crossref","first-page":"6896","DOI":"10.1039\/D0SC06426B","article-title":"3D-visualization of amyloid-\u03b2 oligomer interactions with lipid membranes by cryo-electron tomography","volume":"12","author":"Tian","year":"2021","journal-title":"Chem. Sci."},{"key":"10.1016\/j.ijbiomac.2023.124231_bb0395","doi-asserted-by":"crossref","first-page":"9686","DOI":"10.1039\/D0CP06456D","article-title":"Conformation-specific perturbation of membrane dynamics by structurally distinct oligomers of Alzheimer\u2019s amyloid-\u03b2 peptide","volume":"23","author":"Madhu","year":"2021","journal-title":"Phys. Chem. Chem. Phys."},{"key":"10.1016\/j.ijbiomac.2023.124231_bb0400","doi-asserted-by":"crossref","first-page":"4776","DOI":"10.1021\/acschemneuro.9b00264","article-title":"Amyloid-\u03b2 peptide-lipid bilayer interaction investigated by supercritical angle fluorescence","volume":"10","author":"Dubois","year":"2019","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.ijbiomac.2023.124231_bb0405","doi-asserted-by":"crossref","first-page":"16024","DOI":"10.1021\/acs.langmuir.9b02484","article-title":"Fibrillar and nonfibrillar amyloid Beta structures drive two modes of membrane-mediated toxicity","volume":"35","author":"Vander Zanden","year":"2019","journal-title":"Langmuir"},{"key":"10.1016\/j.ijbiomac.2023.124231_bb0410","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1126\/science.1242077","article-title":"Human LilrB2 is a \u03b2-amyloid receptor and its murine homolog PirB regulates synaptic plasticity in an Alzheimer\u2019s model","volume":"341","author":"Kim","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.ijbiomac.2023.124231_bb0415","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.jneumeth.2010.12.001","article-title":"Specificity and sensitivity of the abeta oligomer ELISA","volume":"195","author":"Klaver","year":"2011","journal-title":"J. Neurosci. Methods"},{"key":"10.1016\/j.ijbiomac.2023.124231_bb0420","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.jneumeth.2008.09.002","article-title":"Characterisation of two antibodies to oligomeric abeta and their use in ELISAs on human brain tissue homogenates","volume":"176","author":"van Helmond","year":"2009","journal-title":"J. Neurosci. Methods"},{"key":"10.1016\/j.ijbiomac.2023.124231_bb0425","doi-asserted-by":"crossref","first-page":"12001","DOI":"10.1021\/ja200951f","article-title":"Single molecule tracking analysis reveals that the surface mobility of amyloid oligomers is driven by their conformational structure","volume":"133","author":"Calamai","year":"2011","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.ijbiomac.2023.124231_bb0430","first-page":"57592","article-title":"A11-positive \u03b2-amyloid oligomer preparation and assessment using dot blotting analysis","author":"Chunhui","year":"2018","journal-title":"J. Vis. Exp."},{"key":"10.1016\/j.ijbiomac.2023.124231_bb0435","doi-asserted-by":"crossref","first-page":"9870","DOI":"10.1038\/s41598-019-46306-5","article-title":"A rationally designed humanized antibody selective for amyloid Beta oligomers in Alzheimer\u2019s disease","volume":"9","author":"Gibbs","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ijbiomac.2023.124231_bb0440","doi-asserted-by":"crossref","first-page":"35186","DOI":"10.1038\/srep35186","article-title":"Fabrication of an antibody-aptamer sandwich assay for electrochemical evaluation of levels of \u03b2-amyloid oligomers","volume":"6","author":"Zhou","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ijbiomac.2023.124231_bb0445","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1002\/ana.20524","article-title":"Amyloid-beta oligomers are inefficiently measured by enzyme-linked immunosorbent assay","volume":"58","author":"Stenh","year":"2005","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.ijbiomac.2023.124231_bb0450","doi-asserted-by":"crossref","first-page":"2884","DOI":"10.1523\/JNEUROSCI.1675-13.2014","article-title":"A sensitive a\u03b2 oligomer assay discriminates Alzheimer\u2019s and aged control cerebrospinal fluid","volume":"34","author":"Savage","year":"2014","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ijbiomac.2023.124231_bb0455","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1021\/acschemneuro.6b00381","article-title":"Surface assay for specific detection of soluble amyloid oligomers utilizing pronucleon peptides instead of antibodies","volume":"8","author":"Matveeva","year":"2017","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.ijbiomac.2023.124231_bb0460","doi-asserted-by":"crossref","first-page":"7157","DOI":"10.1021\/acsami.8b21928","article-title":"MnCO3 as a new electrochemiluminescence emitter for ultrasensitive bioanalysis of \u03b2-Amyloid1\u201342 oligomers based on site-directed immobilization of antibody","volume":"11","author":"Jia","year":"2019","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.ijbiomac.2023.124231_bb0465","article-title":"A\u03b2 oligomer induced cognitive impairment and evaluation of ACU193-MNS-based MRI in rabbit","volume":"6","author":"Rozema","year":"2020","journal-title":"Alzheimer\u2019s Dement. (New York, N. Y.)"},{"key":"10.1016\/j.ijbiomac.2023.124231_bb0470","doi-asserted-by":"crossref","first-page":"4913","DOI":"10.1073\/pnas.83.13.4913","article-title":"Abnormal phosphorylation of the microtubule-associated protein tau (tau) in alzheimer cytoskeletal pathology","volume":"83","author":"Grundke-Iqbal","year":"1986","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ijbiomac.2023.124231_bb0475","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.stemcr.2021.01.019","article-title":"Adult hippocampal neurogenesis in aging and Alzheimer\u2019s disease","volume":"16","author":"Babcock","year":"2021","journal-title":"Stem Cell Reports."},{"key":"10.1016\/j.ijbiomac.2023.124231_bb0480","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1093\/hmg\/5.Supplement_1.1449","article-title":"The presenilin genes: a new gene family involved in alzheimer disease pathology","volume":"5","author":"Cruts","year":"1996","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ijbiomac.2023.124231_bb0485","doi-asserted-by":"crossref","first-page":"4725","DOI":"10.1073\/pnas.92.11.4725","article-title":"Apolipoprotein E and alzheimer disease","volume":"92","author":"Strittmatter","year":"1995","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ijbiomac.2023.124231_bb0490","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1186\/s13024-018-0299-8","article-title":"Advances in developing novel therapeutic strategies for Alzheimer's disease","volume":"13","author":"Cao","year":"2018","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.ijbiomac.2023.124231_bb0495","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.3390\/biom12101409","article-title":"Alzheimer\u2019s disease: challenges and a therapeutic opportunity to treat it with a neurotrophic compound","volume":"12","author":"Baazaoui","year":"2022","journal-title":"Biomolecules."},{"key":"10.1016\/j.ijbiomac.2023.124231_bb0500","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1093\/brain\/awad005","article-title":"Anti-amyloid antibody therapies in Alzheimer's disease","volume":"146","author":"Perneczky","year":"2023","journal-title":"Brain"},{"key":"10.1016\/j.ijbiomac.2023.124231_bb0505","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2022.870517","article-title":"Impact of anti-amyloid-\u03b2 monoclonal antibodies on the pathology and clinical profile of Alzheimer\u2019s disease: a focus on aducanumab and lecanemab","volume":"14","author":"Shi","year":"2022","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.ijbiomac.2023.124231_bb0510","doi-asserted-by":"crossref","first-page":"2474","DOI":"10.1016\/j.ymthe.2022.03.024","article-title":"The development of ADAM10 endocytosis inhibitors for the treatment of Alzheimer's disease","volume":"30","author":"Musardo","year":"2022","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ijbiomac.2023.124231_bb0515","doi-asserted-by":"crossref","first-page":"3629","DOI":"10.3390\/cells11223629","article-title":"Intranasal peptide therapeutics: a promising avenue for overcoming the challenges of traditional CNS drug development","volume":"11","author":"Bose","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.ijbiomac.2023.124231_bb0520","doi-asserted-by":"crossref","first-page":"10948","DOI":"10.1038\/ncomms10948","article-title":"Kinetic analysis reveals the diversity of microscopic mechanisms through which molecular chaperones suppress amyloid formation","volume":"7","author":"Arosio","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ijbiomac.2023.124231_bb0525","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1038\/s42003-019-0612-2","article-title":"Autocatalytic amplification of alzheimer-associated A\u03b242 peptide aggregation in human cerebrospinal fluid","volume":"2","author":"Frankel","year":"2019","journal-title":"Commun. Biol."},{"key":"10.1016\/j.ijbiomac.2023.124231_bb0530","doi-asserted-by":"crossref","first-page":"eabb2639","DOI":"10.1126\/scitranslmed.abb2639","article-title":"Antibody semorinemab reduces tau pathology in a transgenic mouse model and engages tau in patients with Alzheimer's disease","volume":"13","author":"Ayalon","year":"2021","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ijbiomac.2023.124231_bb0535","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.aal2021","article-title":"The amyloid-\u03b2 oligomer A\u03b2*56 induces specific alterations in neuronal signaling that lead to tau phosphorylation and aggregation","volume":"10","author":"Amar","year":"2017","journal-title":"Sci. Signal."},{"key":"10.1016\/j.ijbiomac.2023.124231_bb0540","doi-asserted-by":"crossref","first-page":"8545","DOI":"10.1074\/jbc.271.15.8545","article-title":"Arrest of \u03b2-amyloid fibril formation by a pentapeptide ligand","volume":"271","author":"Tjernberg","year":"1996","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ijbiomac.2023.124231_bb0545","doi-asserted-by":"crossref","first-page":"12601","DOI":"10.1074\/jbc.272.19.12601","article-title":"Controlling amyloid \u03b2-peptide fibril formation with protease-stable ligand","volume":"272","author":"Tjernberg","year":"1997","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ijbiomac.2023.124231_bb0550","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.regpep.2004.03.013","article-title":"Eight-residue A\u03b2 peptides inhibit the aggregation and enzymatic activity of A\u03b242","volume":"120","author":"Matsunaga","year":"2004","journal-title":"Regul. Pept."},{"key":"10.1016\/j.ijbiomac.2023.124231_bb0555","doi-asserted-by":"crossref","first-page":"3570","DOI":"10.1021\/bi982119e","article-title":"Recognition sequence design for peptidyl modulators of \u03b2-amyloid aggregation and toxicity","volume":"38","author":"Pallitto","year":"1999","journal-title":"Biochemistry"},{"key":"10.1016\/j.ijbiomac.2023.124231_bb0560","doi-asserted-by":"crossref","first-page":"7882","DOI":"10.1021\/bi002734u","article-title":"Structure\u2212Function relationships for inhibitors of \u03b2-amyloid toxicity containing the recognition sequence KLVFF","volume":"40","author":"Lowe","year":"2001","journal-title":"Biochemistry"},{"key":"10.1016\/j.ijbiomac.2023.124231_bb0565","doi-asserted-by":"crossref","first-page":"9561","DOI":"10.3390\/s22239561","article-title":"The real-time validation of the effectiveness of third-generation hyperbranched Poly(\u025b-lysine) dendrons-modified KLVFF sequences to bind amyloid-\u03b2(1\u201342) peptides using an optical waveguide light-mode spectroscopy system","volume":"22","author":"Perugini","year":"2022","journal-title":"Sensors (Basel)"},{"key":"10.1016\/j.ijbiomac.2023.124231_bb0570","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.1021\/bi701415b","article-title":"Designing peptide inhibitors for oligomerization and toxicity of Alzheimer's \u03b2-amyloid peptide","volume":"47","author":"Austen","year":"2008","journal-title":"Biochemistry"},{"key":"10.1016\/j.ijbiomac.2023.124231_bb0575","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1038\/nm0798-822","article-title":"Beta-sheet breaker peptides inhibit fibrillogenesis in a rat brain model of amyloidosis: implications for Alzheimer\u2019s therapy","volume":"4","author":"Claudio","year":"1998","journal-title":"Nat. Med."},{"key":"10.1016\/j.ijbiomac.2023.124231_bb0580","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1096\/fj.01-0841fje","article-title":"Reduction of amyloid load and cerebral damage in a transgenic mouse model of Alzheimer\u2019s disease by treatment with a beta-sheet breaker peptide","volume":"16","author":"Permanne","year":"2002","journal-title":"FASEB J."},{"key":"10.1016\/j.ijbiomac.2023.124231_bb0585","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.nbd.2004.08.007","article-title":"In vitro model of neurotoxicity of A\u03b21-42 and neuroprotection by a pentapeptide: irreversible events during the first hour","volume":"17","author":"Datki","year":"2004","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.ijbiomac.2023.124231_bb0590","doi-asserted-by":"crossref","first-page":"991","DOI":"10.3233\/JAD-2010-1297","article-title":"LPYFDa neutralizes amyloid-\u03b2-induced memory impairment and toxicity","volume":"19","author":"Granic","year":"2010","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.ijbiomac.2023.124231_bb0595","doi-asserted-by":"crossref","first-page":"11242","DOI":"10.1074\/jbc.M113.537472","article-title":"Computational and experimental studies on \u03b2-sheet breakers targeting A\u03b21-40 fibrils","volume":"289","author":"Minicozzi","year":"2014","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ijbiomac.2023.124231_bb0600","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1016\/j.peptides.2003.08.005","article-title":"The neuroprotective peptide NAP inhibits the aggregation of the beta-amyloid peptide","volume":"24","author":"Ashur-Fabian","year":"2003","journal-title":"Peptides"},{"key":"10.1016\/j.ijbiomac.2023.124231_bb0605","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/S1474-4422(14)70088-2","article-title":"Davunetide in patients with progressive supranuclear palsy: a randomised, double-blind, placebo-controlled phase 2\/3 trial","volume":"13","author":"Boxer","year":"2014","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.ijbiomac.2023.124231_bb0610","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1021\/acschemneuro.2c00047","article-title":"Ganglioside nanocluster-targeting peptidyl inhibitor prevents amyloid \u03b2 fibril formation on the neuronal membrane","volume":"13","author":"Matsubara","year":"2022","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.ijbiomac.2023.124231_bb0615","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1021\/acschemneuro.2c00712","article-title":"Atrial natriuretic peptide associated with cardiovascular diseases inhibits amyloid - \u03b2 aggregation via cross-seeding","volume":"14","author":"Tang","year":"2023","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.ijbiomac.2023.124231_bb0620","doi-asserted-by":"crossref","first-page":"8898","DOI":"10.1021\/bi050225s","article-title":"Design of peptidyl compounds that affect \u03b2-amyloid aggregation: importance of surface tension and context","volume":"44","author":"Gibson","year":"2005","journal-title":"Biochemistry"},{"key":"10.1016\/j.ijbiomac.2023.124231_bb0625","doi-asserted-by":"crossref","first-page":"3522","DOI":"10.1021\/ja0600678","article-title":"Stoichiometric inhibition of amyloid \u03b2-protein aggregation with peptides containing alternating \u03b1, \u03b1-disubstituted amino acids","volume":"128","author":"Etienne","year":"2006","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.ijbiomac.2023.124231_bb0630","doi-asserted-by":"crossref","DOI":"10.1002\/psc.3386","article-title":"Identification of \u03b2-aminopyrrolidine containing peptides as \u03b2-amyloid aggregation inhibitors for Alzheimer's disease","volume":"28","author":"Preetham","year":"2022","journal-title":"J. Pept. Sci."},{"key":"10.1016\/j.ijbiomac.2023.124231_bb0635","doi-asserted-by":"crossref","first-page":"21975","DOI":"10.1039\/D2CP02601E","article-title":"Mechanistic insights into the mitigation of A\u03b2 aggregation and protofibril destabilization by a d-enantiomeric decapeptide rk10","volume":"24","author":"Singh","year":"2022","journal-title":"Phys. Chem. Chem. Phys."},{"key":"10.1016\/j.ijbiomac.2023.124231_bb0640","doi-asserted-by":"crossref","first-page":"40730","DOI":"10.1074\/jbc.M305466200","article-title":"Targeted control of kinetics of \u03b2-amyloid self-association by surface tension-modifying peptides","volume":"278","author":"Kim","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ijbiomac.2023.124231_bb0645","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1002\/bip.21151","article-title":"Rationally designed dehydroalanine (\u0394Ala)-containing peptides inhibit amyloid-\u03b2 (A\u03b2) peptide aggregation","volume":"91","author":"Rangachari","year":"2009","journal-title":"Biopolymers"},{"key":"10.1016\/j.ijbiomac.2023.124231_bb0650","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.ejmech.2008.03.036","article-title":"Synthesis and activity of fibrillogenesis peptide inhibitors related to the 17\u201321 \u03b2-amyloid sequence","volume":"44","author":"Giordano","year":"2009","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ijbiomac.2023.124231_bb0655","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.1016\/j.peptides.2010.06.033","article-title":"Development of retro-inverso peptides as anti-aggregation drugs for \u03b2-amyloid in Alzheimer's disease","volume":"31","author":"Matharu","year":"2010","journal-title":"Peptides"},{"key":"10.1016\/j.ijbiomac.2023.124231_bb0660","doi-asserted-by":"crossref","first-page":"3261","DOI":"10.1021\/bi100144m","article-title":"Development of a proteolytically stable retro-inverso peptide inhibitor of \u03b2-amyloid oligomerization as a potential novel treatment for Alzheimer\u2019s disease","volume":"49","author":"Taylor","year":"2010","journal-title":"Biochemistry"},{"key":"10.1016\/j.ijbiomac.2023.124231_bb0665","doi-asserted-by":"crossref","first-page":"5959","DOI":"10.1016\/j.ejmech.2011.10.008","article-title":"Sugar-based peptidomimetics inhibit amyloid \u03b2-peptide aggregation","volume":"46","author":"Dorgeret","year":"2011","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ijbiomac.2023.124231_bb0670","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1021\/acs.jmedchem.5b01629","article-title":"Designed glycopeptidomimetics disrupt protein-protein interactions mediating amyloid \u03b2-peptide aggregation and restore neuroblastoma cell viability","volume":"59","author":"Kaffy","year":"2016","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ijbiomac.2023.124231_bb0675","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1002\/bip.22670","article-title":"(R)-\u03b1-trifluoromethylalanine containing short peptide in the inhibition of amyloid peptide fibrillation","volume":"104","author":"Botz","year":"2015","journal-title":"Biopolymers"},{"key":"10.1016\/j.ijbiomac.2023.124231_bb0680","doi-asserted-by":"crossref","first-page":"6791","DOI":"10.1021\/bi982824n","article-title":"Modified-peptide inhibitors of amyloid Beta-peptide polymerization","volume":"38","author":"Findeis","year":"1999","journal-title":"Biochemistry"},{"key":"10.1016\/j.ijbiomac.2023.124231_bb0685","doi-asserted-by":"crossref","first-page":"231","DOI":"10.3109\/13506120108993819","article-title":"Characterization of cholyl-leu-val-phe-pheala-OH as an inhibitor of amyloid betapeptide polymerization","volume":"8","author":"Findeis","year":"2001","journal-title":"Amyloid"},{"key":"10.1016\/j.ijbiomac.2023.124231_bb0690","doi-asserted-by":"crossref","first-page":"388","DOI":"10.2174\/138955712800493942","article-title":"A survey of peptides with effective therapeutic potential in Alzheimer\u2019s disease rodent models or in human clinical studies","volume":"12","author":"Sun","year":"2012","journal-title":"mini-reviewsMed. Chem."},{"key":"10.1016\/j.ijbiomac.2023.124231_bb0695","doi-asserted-by":"crossref","first-page":"3991","DOI":"10.1007\/s00044-012-0386-2","article-title":"Synthesis of d-amino acid peptides and their effect on beta-amyloid aggregation and toxicity in transgenic Caenorhabditis elegans","volume":"22","author":"Jagota","year":"2013","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.ijbiomac.2023.124231_bb0700","first-page":"2015","article-title":"Cognitive-performance recovery of Alzheimer's disease model mice by modulation of early soluble amyloidal assemblies","volume":"121","author":"Frydman-Marom","year":"2009","journal-title":"AngewChemie."},{"key":"10.1016\/j.ijbiomac.2023.124231_bb0705","doi-asserted-by":"crossref","first-page":"3378","DOI":"10.1021\/acschemneuro.2c00402","article-title":"Multiple actions of H 2 S - releasing peptides in human \u03b2 - amyloid expressing C. elegans","volume":"13","author":"Ali","year":"2022","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.ijbiomac.2023.124231_bb0710","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1002\/cbic.200300631","article-title":"Selection of D-amino-acid peptides that bind to Alzheimer's disease amyloid peptide A\u03b21-42 by mirror image phage display","volume":"4","author":"Wiesehan","year":"2003","journal-title":"ChemBioChem."},{"key":"10.1016\/j.ijbiomac.2023.124231_bb0715","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1002\/cmdc.200800273","article-title":"Reduction of Alzheimers disease amyloid plaque load in transgenic mice by D3, a D-enantiomeric peptide identified by mirror image phage display","volume":"3","author":"Van Groen","year":"2008","journal-title":"ChemMedChem"},{"key":"10.1016\/j.ijbiomac.2023.124231_bb0720","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1002\/cmdc.200800289","article-title":"In vitro and in vivo staining characteristics of small, fluorescent, A\u03b242-binding D-enantiomeric peptides in transgenic AD mouse models","volume":"4","author":"Van Groen","year":"2009","journal-title":"ChemMedChem"},{"key":"10.1016\/j.ijbiomac.2023.124231_bb0725","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1021\/cn100057j","article-title":"Oral treatment with the d-enantiomeric peptide D3 improves the pathology and behavior of alzheimer\u2019s disease transgenic mice","volume":"1","author":"Aileen Funke","year":"2010","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.ijbiomac.2023.124231_bb0730","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1089\/rej.2009.0926","article-title":"Transport of alzheimer disease amyloid-\u03b2-binding d-amino acid peptides across an in vitro blood-brain barrier model","volume":"13","author":"Liu","year":"2010","journal-title":"Rejuv. Res."},{"key":"10.1016\/j.ijbiomac.2023.124231_bb0735","doi-asserted-by":"crossref","first-page":"9906","DOI":"10.1021\/bi060837s","article-title":"N-methylated peptide inhibitors of \u03b2-amyloid aggregation and toxicity. optimization of the inhibitor structure","volume":"45","author":"Kokkoni","year":"2006","journal-title":"Biochemistry"},{"key":"10.1016\/j.ijbiomac.2023.124231_bb0740","doi-asserted-by":"crossref","first-page":"8338","DOI":"10.1021\/bi300415v","article-title":"The N-methylated peptide SEN304 powerfully inhibits A\u03b21\u201342 toxicity by perturbing oligomer formation","volume":"51","author":"Amijee","year":"2012","journal-title":"Biochemistry"},{"key":"10.1016\/j.ijbiomac.2023.124231_bb0745","doi-asserted-by":"crossref","first-page":"2929","DOI":"10.1021\/acschemneuro.8b00071","article-title":"Genesis of neuroprotective peptoid from a \u03b2 30\u201334 inhibits a \u03b2 aggregation and AChE activity","volume":"9","author":"Pradhan","year":"2018","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.ijbiomac.2023.124231_bb0750","first-page":"246","article-title":"Short peptoid evolved from the key hydrophobic stretch of amyloid- \u03b2 42 peptide serves as a potent therapeutic lead of Alzheimer's disease","volume":"14","author":"Roy","year":"2023","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.ijbiomac.2023.124231_bb0755","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1021\/ol203074p","article-title":"Synthesis of a new class of bis(thiourea)hydrazide pseudopeptides as potential inhibitors of \u03b2-sheet aggregation","volume":"14","author":"Klein","year":"2012","journal-title":"Org. Lett."},{"key":"10.1016\/j.ijbiomac.2023.124231_bb0760","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1021\/bi0259857","article-title":"Probing the role of backbone hydrogen bonding in \u03b2-amyloid fibrils with inhibitor peptides containing ester bonds at alternate positions","volume":"42","author":"Gordon","year":"2003","journal-title":"Biochemistry"},{"key":"10.1016\/j.ijbiomac.2023.124231_bb0765","doi-asserted-by":"crossref","first-page":"5206","DOI":"10.1039\/C3CC46685J","article-title":"\u03b3-AApeptide-based small-molecule ligands that inhibit A\u03b2 aggregation","volume":"50","author":"Wu","year":"2014","journal-title":"Chem. Commun."},{"key":"10.1016\/j.ijbiomac.2023.124231_bb0770","doi-asserted-by":"crossref","first-page":"983","DOI":"10.3233\/JAD-2012-121324","article-title":"\u03b2-alanyl-L-histidine rescues cognitive deficits caused by feeding a high fat diet in a transgenic mouse model of Alzheimer's disease","volume":"33","author":"Herculano","year":"2013","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.ijbiomac.2023.124231_bb0775","doi-asserted-by":"crossref","first-page":"149","DOI":"10.3233\/JAD-150767","article-title":"Effect of Anserine\/Carnosine supplementation on verbal episodic memory in elderly people","volume":"50","author":"Hisatsune","year":"2016","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.ijbiomac.2023.124231_bb0780","doi-asserted-by":"crossref","first-page":"2410","DOI":"10.1002\/chem.201304253","article-title":"Cyclic peptides as inhibitors of amyloid fibrillation","volume":"20","author":"Luo","year":"2014","journal-title":"Chem. Eur. J."},{"key":"10.1016\/j.ijbiomac.2023.124231_bb0785","doi-asserted-by":"crossref","first-page":"7639","DOI":"10.1016\/j.tet.2014.07.097","article-title":"Structure-based study of antiamyloidogenic cyclic D, L-a-peptides","volume":"70","author":"Chemerovski-glikman","year":"2014","journal-title":"Tetrahedron"},{"key":"10.1016\/j.ijbiomac.2023.124231_bb0790","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1039\/D1CB00235J","article-title":"Combating amyloid-induced cellular toxicity and stiffness by designer peptidomimetics","volume":"3","author":"Konar","year":"2022","journal-title":"RSC Chem. Biol."},{"key":"10.1016\/j.ijbiomac.2023.124231_bb0795","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1039\/D2MD00019A","article-title":"Copper chelating cyclic peptidomimetic inhibits A\u03b2 fibrillogenesis","volume":"13","author":"Kalita","year":"2022","journal-title":"RSC Med. Chem."},{"key":"10.1016\/j.ijbiomac.2023.124231_bb0800","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S1074-5521(03)00022-X","article-title":"Conformational restriction via cyclization in \u03b2-amyloid peptide A\u03b21-28 leads to an inhibitor of A\u03b21-28 amyloidogenesis and cytotoxicity","volume":"10","author":"Kapurniotu","year":"2003","journal-title":"Chem. Biol."},{"key":"10.1016\/j.ijbiomac.2023.124231_bb0805","doi-asserted-by":"crossref","first-page":"8236","DOI":"10.1002\/anie.201405109","article-title":"Rational design and identification of a non-peptidic aggregation inhibitor of amyloid-\u03b2 based on a pharmacophore motif obtained from cyclo[-lys-leu-val-phe-phe-]","volume":"53","author":"Arai","year":"2014","journal-title":"Angew. Chemie - Int. Ed."},{"key":"10.1016\/j.ijbiomac.2023.124231_bb0810","doi-asserted-by":"crossref","first-page":"3474","DOI":"10.1021\/ja310064v","article-title":"In vitro and mechanistic studies of an antiamyloidogenic self-assembled cyclic D, L-\u03b1-peptide architecture","volume":"135","author":"Richman","year":"2013","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.ijbiomac.2023.124231_bb0815","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2210766119","article-title":"Early diagnosis and treatment of Alzheimer's disease by targeting toxic soluble A\u03b2 oligomers","volume":"119","author":"Habashi","year":"2022","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.ijbiomac.2023.124231_bb0820","doi-asserted-by":"crossref","first-page":"3058","DOI":"10.1021\/acs.jmedchem.2c02049","article-title":"Aza-residue modulation of cyclic D, L-\u03b1-peptide nanotube assembly with enhanced anti-amyloidogenic activity","volume":"66","author":"Habashi","year":"2023","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ijbiomac.2023.124231_bb0825","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1146\/annurev.neuro.31.060407.125529","article-title":"Active and passive immunotherapy for neurodegenerative disorders","volume":"31","author":"Brody","year":"2008","journal-title":"Annu. Rev. Neurosci."},{"key":"10.1016\/j.ijbiomac.2023.124231_bb0830","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/alzrt246","article-title":"Perspectives on future alzheimer therapies: amyloid-\u03b2 protofibrils-a new target for immunotherapy with BAN2401 in Alzheimer's disease","volume":"6","author":"Lannfelt","year":"2014","journal-title":"Alzheimers Res. Ther."},{"key":"10.1016\/j.ijbiomac.2023.124231_bb0835","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1073\/pnas.93.1.452","article-title":"Monoclonal antibodies inhibit in vitro fibrillar aggregation of the alzheimer \u03b2-amyloid peptide","volume":"93","author":"Solomon","year":"1996","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ijbiomac.2023.124231_bb0840","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1038\/22124","article-title":"Immunization withamyloid-b attenuates alzheimer- disease-likepathology in thePDAPPmouse","volume":"400","author":"Schenk","year":"1999","journal-title":"Nature"},{"key":"10.1016\/j.ijbiomac.2023.124231_bb0845","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1212\/01.WNL.0000073623.84147.A8","article-title":"Subacute meningoencephalitis in a subset of patients with AD after A\u03b242 immunization","volume":"61","author":"Orgogozo","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.ijbiomac.2023.124231_bb0850","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1212\/01.WNL.0000159740.16984.3C","article-title":"Clinical effect of AB immunization(AN1792) in patients with AD in an interrupted trial","volume":"64","author":"Gilman","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.ijbiomac.2023.124231_bb0855","doi-asserted-by":"crossref","first-page":"243","DOI":"10.3233\/JAD-2009-1118","article-title":"Anti-amyloid-\u03b2 immunotherapy in Alzheimer\u2019s disease: ACC-001 clinical trials are ongoing","volume":"17","author":"Ryan","year":"2009","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.ijbiomac.2023.124231_bb0860","doi-asserted-by":"crossref","first-page":"948","DOI":"10.4161\/hv.6.11.13217","article-title":"AFFITOME\u00ae technology in neurodegenerative diseases: the doubling advantage","volume":"6","author":"Schneeberger","year":"2010","journal-title":"Hum. Vacc."},{"key":"10.1016\/j.ijbiomac.2023.124231_bb0865","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s13195-015-0108-3","article-title":"Long-term treatment with active A\u03b2 immunotherapy with CAD106 in mild Alzheimer's disease","volume":"7","author":"Farlow","year":"2015","journal-title":"Alzheimers Res. Ther."},{"key":"10.1016\/j.ijbiomac.2023.124231_bb0870","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1038\/78682","article-title":"Peripherally administered antibodies against amyloid beta-peptide enter the central nervous system and reduce pathology in a mouse model of alzheimer disease","volume":"6","author":"Bard","year":"2000","journal-title":"Nat. Med."},{"key":"10.1016\/j.ijbiomac.2023.124231_bb0875","doi-asserted-by":"crossref","first-page":"8850","DOI":"10.1073\/pnas.151261398","article-title":"Peripheral anti-A\u03b2 antibody alters CNS and plasma A\u03b2 clearance and decreases brain A\u03b2 burden in a mouse model of Alzheimer's disease","volume":"98","author":"DeMattos","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ijbiomac.2023.124231_bb0880","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s13195-016-0181-2","article-title":"Safety and tolerability of BAN2401 - a clinical study in Alzheimer\u2019s disease with a protofibril selective A\u03b2 antibody","volume":"8","author":"Logovinsky","year":"2016","journal-title":"Alzheimers Res. Ther."},{"key":"10.1016\/j.ijbiomac.2023.124231_bb0885","first-page":"135","article-title":"Solanezumab for the treatment of mild-to-moderate Alzheimer's disease, expert rev","volume":"8","author":"Imbimbo","year":"2012","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.ijbiomac.2023.124231_bb0890","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1073\/pnas.1111232108","article-title":"Structure-based design of conformation- and sequence-specific antibodies against amyloid \u03b2","volume":"109","author":"Perchiacca","year":"2012","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.ijbiomac.2023.124231_bb0895","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1016\/j.str.2004.08.005","article-title":"Anatomy of an amyloidogenic intermediate: conversion of \u03b2-sheet to \u03b1-sheet structure in transthyretin at acidic pH","volume":"12","author":"Armen","year":"2004","journal-title":"Structure"},{"key":"10.1016\/j.ijbiomac.2023.124231_bb0900","doi-asserted-by":"crossref","first-page":"11622","DOI":"10.1073\/pnas.0401781101","article-title":"Pauling and Corey\u2019s \u03b1-pleated sheet structure may define the prefibrillar amyloidogenic intermediate in amyloid disease","volume":"101","author":"Armen","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ijbiomac.2023.124231_bb0905","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1021\/ar0500719","article-title":"\u03b1-sheet: the toxic conformer in amyloid diseases?","volume":"39","author":"Daggett","year":"2006","journal-title":"Acc. Chem. Res."},{"key":"10.1016\/j.ijbiomac.2023.124231_bb0910","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.01681","article-title":"Designed \u03b1-sheet peptides inhibit amyloid formation by targeting toxic oligomers","volume":"3","author":"Hopping","year":"2014","journal-title":"elife"},{"key":"10.1016\/j.ijbiomac.2023.124231_bb0915","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1001\/jama.2022.24494","article-title":"Lecanemab gains FDA approval for early alzheimer disease","volume":"329","author":"Larkin","year":"2023","journal-title":"JAMA"},{"key":"10.1016\/j.ijbiomac.2023.124231_bb0920","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1038\/s41582-021-00540-6","article-title":"The approval of aduhelm risks eroding public trust in alzheimer research and the FDA","volume":"17","author":"Karlawish","year":"2021","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.ijbiomac.2023.124231_bb0925","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1001\/jamaneurol.2021.4161","article-title":"Amyloid-related imaging abnormalities in 2 phase 3 studies evaluating aducanumab in patients with early Alzheimer disease","volume":"79","author":"Salloway","year":"2022","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.ijbiomac.2023.124231_bb0930","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2022.862369","article-title":"Amyloid-related imaging abnormalities with anti-amyloid antibodies for the treatment of dementia due to Alzheimer's disease","volume":"13","author":"Withington","year":"2022","journal-title":"Front. Neurol."},{"key":"10.1016\/j.ijbiomac.2023.124231_bb0935","doi-asserted-by":"crossref","first-page":"24251","DOI":"10.1073\/pnas.2006684117","article-title":"Thermodynamic and kinetic design principles for amyloid-aggregation inhibitors","volume":"117","author":"Michaels","year":"2020","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.ijbiomac.2023.124231_bb0940","doi-asserted-by":"crossref","first-page":"14593","DOI":"10.1073\/pnas.1904090116","article-title":"Optimal control strategies for inhibition of protein aggregation","volume":"116","author":"Michaels","year":"2019","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.ijbiomac.2023.124231_bb0945","doi-asserted-by":"crossref","first-page":"10245","DOI":"10.1073\/pnas.1807884115","article-title":"SAR by kinetics for drug discovery in protein misfolding diseases","volume":"115","author":"Chia","year":"2018","journal-title":"Proc. Natl. Acad. Sci."}],"container-title":["International Journal of Biological Macromolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S014181302301125X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S014181302301125X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T10:05:02Z","timestamp":1758881102000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S014181302301125X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":189,"alternative-id":["S014181302301125X"],"URL":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2023.124231","relation":{},"ISSN":["0141-8130"],"issn-type":[{"value":"0141-8130","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A\u03b2-oligomers: A potential therapeutic target for Alzheimer's disease","name":"articletitle","label":"Article Title"},{"value":"International Journal of Biological Macromolecules","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2023.124231","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"124231"}}